UBS Group’s Forbion European Acquisition Corp. Warrants FRBNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,191
Closed -$1.25K 10219
2023
Q2
$1.25K Buy
3,191
+2,172
+213% +$781 ﹤0.01% 7972
2023
Q1
$143 Buy
1,019
+719
+240% +$124 ﹤0.01% 9183
2022
Q4
$45 Buy
+300
New +$43 ﹤0.01% 10488

Other funds holding FRBNW

UBS Group's FRBNW Position: Q3 2023 in Review

UBS Group sold out of Forbion European Acquisition Corp. Warrants (FRBNW) in Q3 2023, closing a stake of 3,191 shares — an estimated $1.25K sold.

UBS Group first reported a position in FRBNW in Q4 2022 and held it in 3 quarters. The position peaked at $1.25K in Q2 2023. 18 funds tracked by Wall St. Rank hold FRBNW as of Q3 2023.

  • UBS Group reported no remaining Forbion European Acquisition Corp. Warrants position as of Q3 2023 after selling out during the quarter.
  • UBS Group sold 3,191 Forbion European Acquisition Corp. Warrants shares in Q3 2023, an estimated $1.25K.
  • UBS Group first reported a position in Forbion European Acquisition Corp. Warrants in Q4 2022 and held it in 3 quarters.
  • UBS Group's Forbion European Acquisition Corp. Warrants position peaked at $1.25K in Q2 2023.
  • 18 funds tracked by Wall St. Rank held Forbion European Acquisition Corp. Warrants as of Q3 2023.

Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.